CYBN
Price
$6.73
Change
+$0.75 (+12.54%)
Updated
Sep 5 closing price
Capitalization
141.65M
PTHS
Price
$28.22
Change
-$4.27 (-13.14%)
Updated
Sep 5 closing price
Capitalization
85.85M
88 days until earnings call
Interact to see
Advertisement

CYBN vs PTHS

Header iconCYBN vs PTHS Comparison
Open Charts CYBN vs PTHSBanner chart's image
Cybin
Price$6.73
Change+$0.75 (+12.54%)
Volume$754.67K
Capitalization141.65M
Pelthos Therapeutics
Price$28.22
Change-$4.27 (-13.14%)
Volume$25.85K
Capitalization85.85M
CYBN vs PTHS Comparison Chart in %
Loading...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYBN vs. PTHS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYBN is a Buy and PTHS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CYBN: $6.73 vs. PTHS: $28.22)
Brand notoriety: CYBN and PTHS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYBN: 153% vs. PTHS: 33%
Market capitalization -- CYBN: $141.65M vs. PTHS: $85.85M
CYBN [@Biotechnology] is valued at $141.65M. PTHS’s [@Biotechnology] market capitalization is $85.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYBN’s FA Score shows that 1 FA rating(s) are green whilePTHS’s FA Score has 0 green FA rating(s).

  • CYBN’s FA Score: 1 green, 4 red.
  • PTHS’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYBN and PTHS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYBN’s TA Score shows that 4 TA indicator(s) are bullish while PTHS’s TA Score has 3 bullish TA indicator(s).

  • CYBN’s TA Score: 4 bullish, 5 bearish.
  • PTHS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CYBN is a better buy in the short-term than PTHS.

Price Growth

CYBN (@Biotechnology) experienced а -10.03% price change this week, while PTHS (@Biotechnology) price change was +19.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

PTHS is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYBN($142M) has a higher market cap than PTHS($85.8M). PTHS YTD gains are higher at: 340.250 vs. CYBN (-23.696). PTHS has higher annual earnings (EBITDA): -8.54M vs. CYBN (-152.51M). CYBN has more cash in the bank: 119M vs. PTHS (59.2K). PTHS has less debt than CYBN: PTHS (2.31M) vs CYBN (44.5M). CYBN (0) and PTHS (0) have equivalent revenues.
CYBNPTHSCYBN / PTHS
Capitalization142M85.8M166%
EBITDA-152.51M-8.54M1,786%
Gain YTD-23.696340.250-7%
P/E RatioN/AN/A-
Revenue00-
Total Cash119M59.2K201,014%
Total Debt44.5M2.31M1,931%
FUNDAMENTALS RATINGS
CYBN: Fundamental Ratings
CYBN
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYBNPTHS
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHYRF0.32N/A
+1.30%
West High Yield Resources Ltd.
JBAXY14.280.09
+0.60%
Julius Baer Group Ltd.
KRDXF395.24N/A
N/A
Kardex Holding AG
PEFDF0.53N/A
N/A
DELFI LTD
QQQFF0.02N/A
N/A
Quizam Media Corporation

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
+12.54%
ATAI - CYBN
41%
Loosely correlated
+0.22%
ABSI - CYBN
34%
Loosely correlated
+2.50%
RXRX - CYBN
34%
Loosely correlated
+1.99%
SPRC - CYBN
29%
Poorly correlated
+4.69%
ABCL - CYBN
29%
Poorly correlated
+1.44%
More

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-13.14%
SONN - PTHS
70%
Closely correlated
-1.72%
KLRS - PTHS
41%
Loosely correlated
-0.86%
LIXT - PTHS
34%
Loosely correlated
+2.24%
MBIO - PTHS
29%
Poorly correlated
-2.72%
CYBN - PTHS
27%
Poorly correlated
+12.54%
More